Valuation: Rhone Ma Holdings

Market Cap 154M 37.65M 32.72M 30.55M 28.04M 52.88M 3.59B 53.8M 360M 141M 1.79B 141M 138M 5.9B P/E 2026 *
9.87x
P/E 2027 * 9.34x
Enterprise Value 154M 37.65M 32.72M 30.55M 28.04M 52.88M 3.59B 53.8M 360M 141M 1.79B 141M 138M 5.9B EV / Sales 2026 *
0.63x
EV / Sales 2027 * 0.58x
Free-Float
15.82%
Yield 2026 *
3.6%
Yield 2027 * 3.88%
05-12 Rhone Ma Holdings Berhad Announces Redesignation of Oei Kok Eong from Independent Non-Executive Director to Senior Independent Non-Executive Director, Effective 12 May 2026 CI
05-12 Rhone Ma Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-14 Rhone Ma Holdings Berhad Announces Final Single-Tier Dividend for the Financial Year Ended 31 December 2025, Payable on July 13, 2026 CI
02-25 Rhone Ma Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
02-25 Hone Ma Holdings Berhad Announces the Appointment of Oei Kok Eong as Director, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces the Retirement of Martin Jeyaratnam A/L Thiagaraj as Chairman of Remuneration Committee, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces the Appointment of Oei Kok Eong as Chairman of Remuneration Committee, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces the Retirement of Martin Jeyaratnam A/L Thiagaraj as Member of Nomination Committee, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces Appointment of Oei Kok Eong as Member of Nomination Committee, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces the Retirement of Martin Jeyaratnam A/L Thiagaraj as Independent Director, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces the Appointment of Oei Kok Eong as Independent and Non Executive Member of Audit Committee, Effective 25 February 2026 CI
02-25 Rhone Ma Holdings Berhad Announces the Retirement of Martin Jeyaratnam A/L Thiagaraj as Independent and Non Executive Member of Audit Committee, Effective 25 February 2026 CI
01-02 Rhone Ma Holdings Berhad Announces Redesignation of Yip Lai Siong from Executive Director to Non Executive Director, Effective January 2, 2026 CI
1 month+0.72%
3 months+1.46%
6 months+1.46%
Current year+0.72%
1 month 0.68
Extreme 0.68
0.7
Current year 0.62
Extreme 0.62
0.72
1 year 0.62
Extreme 0.62
0.72
3 years 0.58
Extreme 0.58
0.8
5 years 0.58
Extreme 0.58
0.8
10 years 0.57
Extreme 0.57
1.34
Manager TitleAgeSince
Chief Executive Officer 55 2015-03-31
Director of Finance/CFO 56 2013-12-31
Chief Operating Officer 38 2021-12-31
Director TitleAgeSince
Chairman 77 2015-03-31
Director/Board Member 55 2015-03-31
Director/Board Member 66 2015-03-31
Date Insider Type Main position Quantity % Market Cap.
1/31/25 Buy

Chief Executive Officer

110,000 0.0497%
9/22/23 Buy

Chief Executive Officer

17,000 0.0077%
9/8/23 Buy

Chief Executive Officer

103,000 0.0466%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+10.32%-0.71% 37.74M
-2.39%-6.36%+47.10%+149.66% 1,024B
-0.76%-4.34%+52.04%+49.09% 618B
-2.33%-4.60%+25.55%+64.44% 443B
+0.68%-1.14%+38.47%+33.36% 349B
-1.66%-3.13%+32.18%+39.79% 297B
-8.96%-10.77%+3.57%+5.50% 264B
-1.37%-7.41%-2.10%-43.67% 209B
-1.63%+0.69%+27.62%+64.23% 208B
+0.72%+0.48%+15.88%+73.64% 162B
Average -1.38%-2.83%+25.06%+43.53% 357.38B
Weighted average by Cap. -0.98%-3.91%+34.56%+70.87%

Financials

2026 *2027 *
Net sales 244M 59.48M 51.69M 48.26M 44.3M 83.54M 5.67B 84.99M 569M 223M 2.83B 223M 218M 9.32B 265M 64.78M 56.3M 52.56M 48.25M 90.98M 6.17B 92.56M 620M 243M 3.08B 243M 238M 10.16B
Net income 15.6M 3.81M 3.31M 3.09M 2.84M 5.35M 363M 5.44M 36.44M 14.27M 181M 14.31M 13.99M 597M 15.6M 3.81M 3.31M 3.09M 2.84M 5.35M 363M 5.44M 36.44M 14.27M 181M 14.31M 13.99M 597M
Net Debt - -
Logo Rhone Ma Holdings
Rhone Ma Holdings Berhad is an investment holding company. The Company's subsidiaries are involved in the provision of end-to-end animal health solutions and the distribution and supply of food ingredients. Its Animal health products and equipment segment includes marketing, trading, distribution and manufacturing of animal health products and equipment and undertaking research and development activities related to animal health, food safety and agriculture in animal health products. Its Food ingredients segment distributes and supplies food ingredients to manufacturers within the food and beverage industry. Its Others segment includes provision of diagnostic laboratory analyses and consultation services to the veterinary, agriculture and food industries, provision of tests and diagnostics services for human healthcare, conducting research and development in biotechnology and distribution of human healthcare and related products, management services and business of livestock.
Employees
-
Date Price Change Volume
26-07-28 MYR 0.6950 -.--% 3,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RHONEMA Stock